0
Views
0
CrossRef citations to date
0
Altmetric
Cell Growth and Development

Induction of Differentiation in v-Ha-ras-Transformed MDCK Cells by Prostaglandin E2 and 8-Bromo-Cyclic AMP Is Associated with a Decrease in Steady-State Level of Inositol 1,4,5-Trisphosphate

&
Pages 57-67 | Received 26 Jun 1989, Accepted 26 Sep 1989, Published online: 01 Apr 2023

Literature Cited

  • Adari H., D. R. Lowy, B. M., Willumsen, C. J., Der, and F. McCormick 1988. Guanosine triphosphatase activating protein (GAP) interacts with the p21 ras effector binding domain. Science 240: 518-521.
  • Alonso, T., R. O., Morgan, J. C., Marvizon, H., Zarbl, and E. Santos 1988. Malignant transformation by ras and other oncogenes produces common alterations in inositol phospholipid signaling pathways. Proc. Natl. Acad. Sci. USA 85: 4271-4275.
  • Ames, B. N., and D. T. Dubin 1960. The role of polyamines in the neutralization of bacteriophage deoxyribonucliec acid. J. Biol. Chem. 235: 769-775.
  • Ballester, R., and O. M. Rosen 1985. Fate of immunoprecipitable protein kinase C in GH3 cells treated with phorbol 12- myristate 13-acetate. J. Biol. Chem. 260: 15194-15199.
  • Barbacid, M. 1987. ras genes. Annu. Rev. Biochem. 56: 779-827.
  • Beckner, S. K., S., Hattori, and T. Y. Shih 1985. The ras oncogene product p21 is not a regulatory component of adenylate cyclase. Nature (London) 317: 71-72.
  • Beckner, S. K., D. E., Wright, and M. C. Lin 1987. Decreased potency of glucagon on transformed-induced MDCK cells does not reflect an alteration of adenylate cyclase components. Endocrinology 121: 1438-1446.
  • Berridge, M. J. 1987. Inositol trisphosphate and diacylglycerol: two interacting second messengers. Annu. Rev. Biochem. 56: 159-193.
  • Bianca, V. D., P. D., Togni, M., Grzeskowiak, L. M., Vicentini, and F. D. Virgilio 1986. Cyclic AMP inhibition of phosphoinositide turnover in human neutrophils. Biochim. Biophys. Acta 886: 441-447.
  • Birrer, M. J., S., Segal, J. S., DeGreve, F., Kave, E. A., Sausville, and J. D. Minna 1988. L-mvc cooperates with ras to transform primary rat embryo fibroblasts. Mol. Cell. Biol. 8: 2668-2673.
  • Bishop, W. R., and R. M. BeU 1988. Mini-review. Functions of diacylglycerol in glycerolipid metabolism, signal transduction and cellular transformation. Oncogene Res. 2: 205-218.
  • Bligh, E. G., and W. J. Dyer 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917.
  • de Chaffoy de Courcelles, D., P., Roevens, and H. Van Belle 1986. Agents that elevate platelet cAMP stimulate the formation of phosphatidylinositol 4-phosphate in intact human platelets. FEBS Lett. 195: 115-118.
  • Der, C. J., T., Finkel, and G. M. Cooper 1986. Biological and biochemical properties of human rasH genes mutated at codon 61. Cell 44: 167-176.
  • Fain, J. N., M. A., Wallace, and R. J. H. Wojcikiewicz 1988. Evidence for involvement of guanine nucleotide-binding regulatory proteins in the activation of phospholipases by hormones. FASEB J. 2: 2569-2574.
  • Faletto, D. L., A. S., Arrow, and I. G. Macara 1985. An early decrease in phosphatidylinositol turnover occurs on induction of Friend cell differentiation and precedes the decrease in c-myc expression. Cell 43: 315-325.
  • Feig, L. A., and G. M. Cooper 1988. Relationship among guanine nucleotide exchange, GTP hydrolysis, and transforming potential of mutated ras proteins. Mol. Cell. Biol. 8: 2472-2478.
  • Filmus, J., and R. N. Buick 1985. Relationship of c-myc expression to differentiation and proliferation of HL-60 cells. Cancer Res. 45: 822-825.
  • Fleischman, L. F., S. B., Chahwala, and L. Cantley 1986. Ras-transformed cells: altered levels of phosphatidyhnositol- 4,5-bisphosphate and catabolites. Science 231: 407-410.
  • Fukami, K., K., Matsuoka, O., Nakanishi, A., Yamakawa, S., Kawai, and T. Takenawa 1988. Antibody to phosphatidylinositol 4,5-bisphosphate inhibits oncogene-induced mitogenesis. Proc. Natl. Acad. Sci. USA 85: 9057-9061.
  • Furth, M. E., L. J., Davis, B., Flenrdelys, and E. M. Scolnick 1982. Monoclonal antibodies to the p21 products of the transforming gene of Harvey sarcoma virus and of the cellular ras family. J. Virol. 43: 294-304.
  • Geny, B., C., LePeuch, H., Cost, M., Basset, and S. Cockcroft 1988. Phorbol esters inhibit inositol phosphate and diacylglycerol formation in proliferating HL 60 cells. Relationship to differentiation. FEBS Lett. 233: 239-243.
  • Guillemette, G., T., Balla, A. J., Baukal, A., Spat, and K. J. Catt 1987. Intracellular receptors for inositol 1,4,5-trisphosphate in angiotensin II target tissues. J. Biol. Chem. 262: 1010-1015.
  • Huang, M., K., Chida, N., Kamata, K., Nose, M., Kato, M. Y., Homma, T., Takenawa, and T. Kuroki 1988. Enhancement of inositol phospholipid metabolism and activation of protein kinase C in ras-transformed rat fibroblasts. J. Biol. Chem. 263: 17975-17980.
  • Imai, A., H., Hattori, M., Takahashi, and Y. Nozawa 1983. Evidence that cyclic AMP may regulate Ca2+-mobilization and phospholipases in thrombin-stimulated human platelets. Biochem. Biophys. Res. Commun. 112: 693-700.
  • Kamata, T., and J. Feramisco 1984. Epidermal growth factor stimulates guanine nucleotide binding activity and phosphorylation of ras oncogene protein. Nature (London) 310: 147-150.
  • Kato, H., S., Kawai, and T. Takenawa 1988. Disappearance of diacylglycerol kinase translocation in ras-transformed cells. Biochem. Biophys. Res. Commun. 154: 959-966.
  • Kelvin, D. J., G., Simard, A., Sue-A-Quan, and J. A. Connolly 1989. Growth factors, signaling pathways, and the regulation of proliferation and differentiation in BC3H1 muscle cells. II. Two signaling pathways distinguished by pertussis toxin and a potential role for the ras oncogene. J. Cell Biol. 108: 169-176.
  • Kelvin, D. J., G., Simard, H. H., Tai, T. P., Yamaguchi, and J. A. Connolly 1989. Growth factors, signaling pathways, and the regulation of proliferation and differentiation in BC3H1 muscle cells. I. A pertussis toxin-sensitive pathway is involved. J. Cell Biol. 108: 159-167.
  • Lacal, J. C, and S. A. Aaronson 1986. Activation of ras p21 transforming properties associated with an increase in the release rate of bound guanine nucleotide. Mol. Cell. Biol. 6: 4214-4220.
  • Lacal, J. C, J., Moscat, and S. A. Aaronson 1987. Novel source of 1,2-diacylglycerol elevated in cells transformed by Ha-ras oncogene. Nature (London) 330: 269-272.
  • Lacal, J. C, P. D. L., Pena, J., Moscat, P., Garcia-Barreno, P. S., Anderson, and S. A. Aaronson 1987. Rapid stimulation of diacylglycerol production in Xenopus oocytes by microinjection of H-ras p21. Science 238: 533-536.
  • Lachman, H. M., and A. I. Skoultchi 1984. Expression of c-myc changes during differentiation of mouse erythroleukemia cells. Nature (London) 310: 592-594.
  • Land, H., L. F., Parada, and R. A. Weinberg 1983. Tumorigenic conversion of primary embryo fibroblast requires at least two cooperating oncogenes. Nature (London) 304: 596-602.
  • Lee, W., M. F., Schwab, D., Westaway, and H. E. Varmus 1985. Augmented expression of normal c-myc is sufficient for cotrans- formants of rat embryo cells with a mutant ras gene. Mol. Cell. Biol. 5: 3345-3356.
  • Lin, M. C, and S. K. Beckner 1983. Induction of hormone receptors and responsiveness during cellular differentiation. Curr. Top. Membr. Transp. 18: 287-315.
  • Lin, M. C, S. K., Beckner, and F. J. Darfler 1985. Characterization of hormone-sensitive Madin-Darby canine kidney cells. Methods Enzymol. 109: 360-365.
  • Lin, M. C, F. J., Darfler, and S. K. Beckner 1987. Induction of glucagon sensitivity in a transformed kidney cell line by prostaglandin E2 and its inhibition by epidermal growth factor. Mol. Cell. Biol. 7: 4324-4328.
  • Macara, I. G. 1989. Elevated phosphocholine concentration in ras-transformed NIH 3T3 cells arises from increased choline kinase activity, not from phosphatidylcholine breakdown. Mol. Cell. Biol. 9: 325-328.
  • Marshall, C. J. 1987. Oncogenes and growth control. 1987. Cell 49: 723-725.
  • Najam, N., T., Clair, R. H., Bassin, and Y. S. Cho-Chung 1986. Cyclic AMP suppresses expression of v-rasH oncogene linked to the mouse mammary tumor virus promoter. Biochem. Biophys. Res. Commun. 134: 436-442.
  • Nishizuka, Y. 1988. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature (London) 334: 661-665.
  • Pastan, I., G. S., Johnson, and W. B. Anderson 1975. Role of cyclic nucleotides in growth control. Annu. Rev. Biochem. 44: 491-522.
  • Porfiri, E., A. V., HoSbrand, and R. G. Wickremasinghe 1988. Granulocytic differentiation of HL60 human promyelocyte leukemia cells is preceded by a reduction in levels of inositol lipid-derived second messengers. Exp. Hematol. 16: 641-646.
  • Preiss, J., C. R., Loomis, W. R., Bishop, R., Stedin, J. E., Niedel, and R. M. Bell 1986. Quantitative measurement of sn-1,2- diacylglycerols present in platelets, hepatocytes, and ras- and sis-transformed normal rat kidney cells. J. Biol. Chem. 261: 8597-8600.
  • Ridgeway, A. A. G., M. W., De Vouge, and B. B. Mukherjee 1988. cAMP inhibits expression of transformation-related properties in Kirsten murine sarcoma virus transformed Balb/c-3T3 cells despite continued presence of p21v-ki-ras. Biochem. Cell Biol. 66: 54-65.
  • Rozengurt, E. 1986. Early signals in the mitogenic response. Science 234: 161-166.
  • Scolnick, E. M., D., Williams, J., Maryak, W., Vass, R. J., Goldberg, and W. P. Parks 1976. Type C particle-positive and type C particle-negative rat cell lines: characterization of the coding capacity of endogenous sarcoma virus-specific RNA. J. Virol. 20: 570-583.
  • Seuwen, K., A., Lagarde, and J. Pouyssegur 1988. Deregulation of hamster fibroblast proliferation by mutated ras oncogenes is not mediated by constitutive activation of phosphoinositide- specific phospholipase C. EMBO J. 7: 161-168.
  • Sigal, I. S., J. B., Gibbs, J. S., D'Alonzo, G. L., Temeles, B. S., Wolanski, S. H., Socher, and E. M. Scolnick 1986. Mutant ras-encoded proteins with altered nucleotide binding exert dominant biological effects. Proc. Natl. Acad. Sci. USA 83: 952-956.
  • Smith, M. R., S. J., DeGudicibus, and D. W. Stacey 1986. Requirement for c-ras proteins during viral oncogene transformation. Nature (London) 320: 540-543.
  • Stacey, D. W., S. R., DeGudicibus, and M. R. Smith 1987. Cellular ras activity and tumor cell proliferation. Exp. Cell Res. 171: 232-242.
  • Sugimoto, Y., M., Noda, H., Kitayama, and Y. Ikawa 1988. Possible involvement of two signaling pathways in induction of neuron-associated properties by v-Ha-ras gene in PC12 cells. J. Biol. Chem. 263: 12102-12108.
  • Tagliaferri, P., T., Clair, M. E., Debortoli, and Y. S. Cho-Chung 1985. Two classes of cAMP analogs synergistically inhibit p21 ras protein synthesis and phenotypic transformation of NIH/ 3T3 cells transfected with Ha-MuSV DNA. Biochem. Biophys. Res. Commun. 130: 1193-1200.
  • Takenawa, T., J., Ishitoya, and T. Nagai 1986. Inhibitory effect of prostaglandin E2, forskolin, and dibutyryl cAMP on arachi- donic acid release and inositol phospholipid metabolism in guinea pig neutrophils. J. Biol. Chem. 261: 1092-1098.
  • Taub, M., L., Chuman, M. H., Saier, and G. Sato 1979. Growth of Madin-Darby canine kidney epithelial cell (MDCK) line in hormone-supplemented, serum-free medium. Proc. Natl. Acad. Sci. USA 76: 3338-3342.
  • Thiele, C. J., C. P., Reynolds, and M. A. Israel 1985. Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. Nature (London) 313: 404-406.
  • Trahey, M., and F. McCormick 1987. A cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not affect oncogenic mutants. Science 238: 542-545.
  • Tsuda, T., Y., Hamamori, T., Yamashita, Y., Fukumoto, and Y. Takai 1986. Involvement of three intracellular messenger systems, protein kinase C, calcium ion and cyclic AMP, in the regulation of c-fos gene expression in Swiss 3T3 cells. FEBS Lett. 208: 39-42.
  • Wakelam, M. J. O., S. A., Davies, M. D., Houslay, I., McKay, C. J., Marshall, and A. Hall 1986. Normal p21Nras couples bombesin and other growth factor receptors to inositol phosphate production. Nature (London) 323: 173-176.
  • Watanabe, T., K., Umegaki, and W. L. Smith 1986. Association of a solubilized prostaglandin E2 receptor from renal medulla with a pertussis toxin-reactive guanine nucleotide regulatory protein. J. Biol. Chem. 26: 13430-13439.
  • Watson, S. P., R. T., McConnell, and E. G. Lapetina 1984. The rapid formation of inositol phosphates in human platelets by thrombin is inhibited by prostacyclin. J. Biol. Chem. 259: 13199-13203.
  • Wolfman, A., and I. G. Macara 1987. Elevated levels of diacylglycerol and decreased phorbol ester sensitivity in ras-transformed fibroblasts. Nature (London) 325: 359-361.
  • Wright, T. M., L. A., Rangan, H. S., Shin, and D. M. Raben 1988. Kinetic analysis of 1,2-diacylglycerol mass levels in cultured fibroblasts. J. Biol. Chem. 263: 9374-9380.
  • Yokohama, H., T., Tanaka, S., Ito, M., Negishi, H., Hayashi, and O. Hayaishi 1988. Prostaglandin E receptor enhancement of catecholamine release may be mediated by phosphoinositide metabolism in bovine adrenal chromaffin cells. J. Biol. Chem. 263: 1119-1122.
  • Yu, C.-L., M.-H., Tsai, and D. W. Stacey 1988. Cellular ras activity and phospholipid metabolism. Cell 52: 63-71.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.